Surmodics, Inc. (NASDAQ:SRDX) headquartered in Eden Prairie, will host a conference call for the investment community to discuss the 4Q20 earnings result on 4th November 2020 at 5:00 PM Eastern Time.
Those interested in listening to the conference call live via the Internet can visit www.surmodics.com
Earnings Expectation
Surmodics, Inc. is reporting fourth quarter financial results on Wednesday 4th November 2020, after market close.
According to analysts surveyed by Thomson Reuters, SRDX is expected to report 4Q20 loss of $ 0.08 per share from revenue of $ 20.77 million.
For the full year, analysts anticipate top line of $ 93.07 million, while looking forward to income of $ 0.22 per share bottom line.
The Company Outlook
Full Year 2020 topline are forecasted in a range of$ 87.00 million ~ $ 91.00 million, where as bottomline are predicted in a range of $ -0.44 ~ $ -0.14 per share
Click Here For More Historical Outlooks Of Surmodics, Inc.
Surmodics, Inc., together with its subsidiaries, provides medical devices and in vitro diagnostic technologies to the healthcare industry in the United States and internationally. The company operates through two segments, Medical Device and In Vitro Diagnostics. The Medical Device segment designs, develops, and manufactures interventional medical devices primarily for the peripheral vascular market; and offers surface modification coating technologies to enhance access, deliverability, and predictable deployment of medical devices, as well as drug delivery coating technologies to provide site-specific drug delivery from the surface of a medical device for the coronary, peripheral, neuro-vascular, urology, and other markets.
